Holmes, F A <br/><br/>
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jun 2002 
 - 903-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdf130  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Confidence Intervals<br/>Docetaxel<br/>Dose-Response Relationship, Drug<br/>Doxorubicin--administration & dosage<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Drug-Related Side Effects and Adverse Reactions<br/>Female<br/>Filgrastim<br/>Follow-Up Studies<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Injections, Subcutaneous<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Paclitaxel--administration & dosage<br/>Polyethylene Glycols<br/>Probability<br/>Recombinant Proteins<br/>Reference Values<br/>Taxoids<br/>Treatment Outcome